Citation Impact and Public Attention Analysis of Benign Prostatic Hyperplasia Research in the Urological Literature
- 1David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
Abstract
ObjectiveTo determine whether the most cited and the most publicly discussed benign prostatic hyperplasia (BPH) literature describe the same body of work, and whether clinicians and patients read different evidence.
MethodsFour Boolean Web of Science searches and four matched Altmetric Explorer searches were run in February 2024, restricted to literature indexed with urologic terminology, and screened in duplicate. Two arms were assembled: the 50 most-cited articles (citation census May 2024) and the 50 with the highest Altmetric Attention Scores. Funding source and intervention focus were hand-coded from the full text of all 100 articles; open-access status came from Unpaywall. Arms were compared with Mann-Whitney U and Fisher exact tests
ResultsEight of 50 articles (16%) appeared in both arms. Citation-selected articles were older (median 2008 versus 2018, p<0.001), more often randomized trials (58% versus 22%, p<0.001), and more often published in urology-specific journals (96% versus 66%, p<0.001). Industry funded 50% versus 18% of articles (p=0.001) and non-industry sources 8% versus 36% (p=0.001). Only 10% of citation-selected articles were open access versus 56% (p<0.001). Attention data were recoverable for only 13 citation-selected articles (median score 9 versus 17). The two arms were cited in the 2026 AUA BPH Guideline at indistinguishable rates (22% versus 20%, p=1.00).
ConclusionsThese are largely distinct bodies of work, separated most decisively by whether they can be read without a subscription, yet both inform guideline development equally. Patients arrive with evidence systematically different from, and no less guideline-relevant than, that underpinning their urologists training.
Related
- Two-dimensional computational fluid dynamics study of urine flow in the prostatic fossa after benign prostatic hyperplasia surgery: a single-patient model
- Intake of foods containing phytochemicals is correlated with benign prostatic hyperplasia development: a long-term follow-up study
- Cumulative average glucose–lipid metabolic obesity index associates with benign prostatic hyperplasia incidence in Chinese middle-aged and older men
- Holmium laser enucleation of the prostate for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia
- Shared mechanisms and therapeutic horizons: exploring the potential interplay between benign prostatic hyperplasia/lower urinary tract symptoms and Alzheimer’s disease
BibTeX
@misc{simo2026citation,
title = {{Citation Impact and Public Attention Analysis of Benign Prostatic Hyperplasia Research in the Urological Literature}},
author = {G. Motchoffo Simo and A. Rizzo and K. Muy and N. Quintanilla and K. Scotland},
howpublished = {medRxiv},
year = {2026},
month = sep,
doi = {10.64898/2026.09.01.26361260},
url = {https://www.medrxiv.org/content/10.64898/2026.09.01.26361260v1},
note = {CC BY},
}
RIS
TY - UNPB
TI - Citation Impact and Public Attention Analysis of Benign Prostatic Hyperplasia Research in the Urological Literature
AU - G. Motchoffo Simo
AU - A. Rizzo
AU - K. Muy
AU - N. Quintanilla
AU - K. Scotland
PY - 2026
DA - 2026/09/01
PB - medRxiv
DO - 10.64898/2026.09.01.26361260
UR - https://www.medrxiv.org/content/10.64898/2026.09.01.26361260v1
AB - ObjectiveTo determine whether the most cited and the most publicly discussed benign prostatic hyperplasia (BPH) literature describe the same body of work, and whether clinicians and patients read different evidence. MethodsFour Boolean Web of Science searches and four matched Altmetric Explorer searches were run in February 2024, restricted to literature indexed with urologic terminology, and screened in duplicate. Two arms were assembled: the 50 most-cited articles (citation census May 2024) and the 50 with the highest Altmetric Attention Scores. Funding source and intervention focus were hand-coded from the full text of all 100 articles; open-access status came from Unpaywall. Arms were compared with Mann-Whitney U and Fisher exact tests ResultsEight of 50 articles (16%) appeared in both arms. Citation-selected articles were older (median 2008 versus 2018, p<0.001), more often randomized trials (58% versus 22%, p<0.001), and more often published in urology-specific journals (96% versus 66%, p<0.001). Industry funded 50% versus 18% of articles (p=0.001) and non-industry sources 8% versus 36% (p=0.001). Only 10% of citation-selected articles were open access versus 56% (p<0.001). Attention data were recoverable for only 13 citation-selected articles (median score 9 versus 17). The two arms were cited in the 2026 AUA BPH Guideline at indistinguishable rates (22% versus 20%, p=1.00). ConclusionsThese are largely distinct bodies of work, separated most decisively by whether they can be read without a subscription, yet both inform guideline development equally. Patients arrive with evidence systematically different from, and no less guideline-relevant than, that underpinning their urologists training.
ER -